Comparative Pharmacology
Head-to-head clinical analysis: ACTONEL WITH CALCIUM COPACKAGED versus CALCIUM SUPPLEMENTS.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ACTONEL WITH CALCIUM COPACKAGED versus CALCIUM SUPPLEMENTS.
ACTONEL WITH CALCIUM (COPACKAGED) vs Calcium Carbonate / Calcium Supplements
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ACTONEL WITH CALCIUM (COPACKAGED) contains risedronate sodium, a bisphosphonate that inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite crystals in bone and inhibiting farnesyl pyrophosphate synthase (FPPS), an enzyme in the mevalonate pathway. This leads to reduced bone turnover and increased bone mineral density. The calcium component is for supplementation to prevent hypocalcemia.
Calcium carbonate is a calcium salt that dissociates in the stomach to release calcium ions. Calcium is essential for nerve transmission, muscle contraction, blood coagulation, and bone mineralization. It acts as a cofactor for various enzymes and maintains cell membrane integrity and permeability.
Actonel (risedronate) 35 mg orally once weekly, taken with 6-8 oz of plain water at least 30 minutes before breakfast. Calcium supplement (e.g., 1250 mg calcium carbonate) taken with food at a different time of day.
1250 mg (500 mg elemental calcium) orally 1-2 times daily with meals; maximum 2500 mg elemental calcium per day.
None Documented
None Documented
Terminal elimination half-life of risedronate is approximately 20 hours for the 5 mg daily dose and 480 hours for the 35 mg weekly dose due to prolonged retention in bone; clinically, the drug accumulates in bone and is slowly released.
Calcium's elimination half-life is approximately 2-4 hours for ionized calcium, with a slower terminal phase of 8-12 hours due to exchange from bone pools. Clinically, serum calcium levels normalize within 4-6 hours after a single dose.
Risedronate is eliminated primarily via renal excretion, with approximately 50% of an absorbed dose excreted unchanged in urine. Unabsorbed drug is eliminated in feces. Total clearance is about 100 mL/min.
Primarily renal (20-30% excreted as calcium), with the remainder reabsorbed in the renal tubules. Fecal excretion accounts for 70-80% of ingested calcium, representing unabsorbed calcium. Biliary excretion is negligible.
Category C
Category A/B
Bisphosphonate and Calcium Supplement
Calcium Supplement